Zoetis Inc. (NYSE:ZTS) Stock Holdings Lowered by Planning Capital Management Corp

Planning Capital Management Corp trimmed its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 75.1% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 273 shares of the company’s stock after selling 824 shares during the period. Planning Capital Management Corp’s holdings in Zoetis were worth $53,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of ZTS. Zions Bancorporation N.A. lifted its position in shares of Zoetis by 11.8% during the 3rd quarter. Zions Bancorporation N.A. now owns 21,036 shares of the company’s stock valued at $4,110,000 after acquiring an additional 2,219 shares during the last quarter. KBC Group NV lifted its position in shares of Zoetis by 3.9% during the 3rd quarter. KBC Group NV now owns 375,167 shares of the company’s stock valued at $73,300,000 after acquiring an additional 14,159 shares during the last quarter. Huntington National Bank lifted its holdings in shares of Zoetis by 5.8% in the third quarter. Huntington National Bank now owns 249,247 shares of the company’s stock valued at $48,698,000 after purchasing an additional 13,757 shares in the last quarter. Plato Investment Management Ltd raised its holdings in shares of Zoetis by 13.2% during the third quarter. Plato Investment Management Ltd now owns 8,088 shares of the company’s stock worth $1,579,000 after acquiring an additional 943 shares in the last quarter. Finally, D Orazio & Associates Inc. purchased a new stake in shares of Zoetis during the third quarter worth $217,000. Institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. JPMorgan Chase & Co. increased their target price on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Stifel Nicolaus raised their price target on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Wednesday, September 18th. Piper Sandler raised their price target on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Finally, BTIG Research lifted their target price on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, August 12th. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average price target of $221.44.

Zoetis Stock Down 1.4 %

Shares of ZTS opened at $174.63 on Friday. The stock has a market cap of $78.79 billion, a price-to-earnings ratio of 32.83, a P/E/G ratio of 2.72 and a beta of 0.90. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92. The company has a 50-day moving average price of $187.61 and a two-hundred day moving average price of $180.02.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. The firm had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same quarter last year, the company earned $1.36 earnings per share. Equities analysts predict that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be issued a dividend of $0.432 per share. The ex-dividend date is Thursday, October 31st. This represents a $1.73 dividend on an annualized basis and a yield of 0.99%. Zoetis’s dividend payout ratio is 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.